Literature DB >> 21734800

Probiotics in hepatology.

Jan Lata1, Jana Jurankova, Marcela Kopacova, Petr Vitek.   

Abstract

The paper provides a basic review of intestinal microflora and its importance in liver diseases. The intestinal microflora has many important functions, above all to maintain the microbial barrier against established as well as potential pathogens. Furthermore, it influences the motility and perfusion of the intestinal wall, stimulates the intestinal immune system and therefore also the so-called common mucosal immune system, reducing bacterial translocation and producing vitamins. Immune homeostasis at mucosal level results from a controlled response to intestinal luminal antigens. In liver cirrhosis, there are many changes in its function, mostly an increase in bacterial overgrowth and translocation. In this review, probiotics and their indications in hepatology are generally discussed. According to recent knowledge, these preparations are indicated in clinical practice only for cases of hepatic encephalopathy. Probiotics are able to decrease the permeability of the intestinal wall, and decrease bacterial translocation and endotoxemia in animal models as well as in clinical studies, which is extremely important in the prevention of complications of liver cirrhosis and infection after liver transplantation. Probiotics could limit oxidative and inflammatory liver damage and, in some situations, improve the histological state, and thus non-alcoholic steatohepatitis could be considered as another possible indication.

Entities:  

Keywords:  Intestinal microflora; Liver cirrhosis; Liver encephalopathy; Non-alcoholic steatohepatitis; Probiotics

Mesh:

Year:  2011        PMID: 21734800      PMCID: PMC3129503          DOI: 10.3748/wjg.v17.i24.2890

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  55 in total

1.  Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.

Authors:  Hidetoshi Kanazawa; Masato Nagino; Satoshi Kamiya; Shunichiro Komatsu; Toshihiko Mayumi; Kenji Takagi; Takashi Asahara; Koji Nomoto; Ryuichiro Tanaka; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

2.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

3.  Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.

Authors:  C Guarner; B A Runyon; S Young; M Heck; M Y Sheikh
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

4.  Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

Authors:  Lin Jia; Mei-Hua Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

5.  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Reinhold A Schiller; Jan M Langrehr; Sven Jonas; Stig Bengmark; Peter Neuhaus
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

6.  Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Authors:  Tilman Martin Bauer; Javier Fernández; Miquel Navasa; Jordi Vila; Juan Rodés
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

7.  Bacterial infection in the pathogenesis of variceal bleeding.

Authors:  J Goulis; D Patch; A K Burroughs
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

8.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

Authors:  Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

9.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

Authors:  Irina A Kirpich; Natalia V Solovieva; Svetlana N Leikhter; Natalia A Shidakova; Oxsana V Lebedeva; Pavel I Sidorov; Tatjana A Bazhukova; Andrej G Soloviev; Shirish S Barve; Craig J McClain; Matt Cave
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

Review 10.  Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis.

Authors:  F Lirussi; E Mastropasqua; S Orando; R Orlando
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
View more
  15 in total

Review 1.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

Review 2.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 3.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

4.  Practical identification of human originated Lactobacillus species by amplified ribosomal DNA restriction analysis (ARDRA) for probiotic use.

Authors:  Mehmet Öztürk; Merve Meterelliyöz
Journal:  Mol Biol Rep       Date:  2015-04-10       Impact factor: 2.316

Review 5.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 6.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

Review 7.  Intestinal permeability in a patient with liver cirrhosis.

Authors:  Jonathan Manuel Aguirre Valadez; Liliana Rivera-Espinosa; Osvely Méndez-Guerrero; Juan Luis Chávez-Pacheco; Ignacio García Juárez; Aldo Torre
Journal:  Ther Clin Risk Manag       Date:  2016-11-18       Impact factor: 2.423

8.  Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction.

Authors:  Wei-Wei Wang; Yu Zhang; Xiao-Bing Huang; Nan You; Lu Zheng; Jing Li
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

9.  Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.

Authors:  Ahmad Shavakhi; Mohammad Minakari; Hassan Firouzian; Raheleh Assali; Azita Hekmatdoost; Gordon Ferns
Journal:  Int J Prev Med       Date:  2013-05

Review 10.  The gut microbiota and host health: a new clinical frontier.

Authors:  Julian R Marchesi; David H Adams; Francesca Fava; Gerben D A Hermes; Gideon M Hirschfield; Georgina Hold; Mohammed Nabil Quraishi; James Kinross; Hauke Smidt; Kieran M Tuohy; Linda V Thomas; Erwin G Zoetendal; Ailsa Hart
Journal:  Gut       Date:  2015-09-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.